ODM-111

DRUG2 trials

Sponsors

Orion Corporation

Conditions

CHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHYChronic Pain due to Ostheoarthritis of the knee

Phase 2

Efficacy and tolerability of ODM-111 in chronic pain due to osteoarthritis of the knee

CompletedCTIS2024-513553-79-00

Orion CorporationChronic Pain due to Ostheoarthritis of the knee

End: 2024-10-28Target: 234Updated: 2024-10-28

Efficacy and tolerability of ODM-111 in chronic pain due to diabetic peripheral neuropathy

CompletedCTIS2024-513595-17-00

Orion CorporationCHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHY

End: 2024-10-28Target: 203Updated: 2024-10-28